Bertram Jacobs
18Patents
9h-index
36Co-inventors
72Inventor score
Filing activity: Mar 12, 1997 → Apr 28, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6004777A | Vectors having enhanced expression, and methods of making and uses thereof | Chemistry; Metallurgy | 75 | Expired |
| US6372455B1 | Recombinant vaccinia viral vectors | Chemistry; Metallurgy | 20 | Expired |
| US7431929B2 | Use of vaccinia virus deleted for the E3L gene as a vaccine vector | Chemistry; Metallurgy | 19 | Expired |
| US9670506B2 | Modified immunization vectors | Emerging Cross-Sectional Technologies | 18 | Active |
| US6942855B2 | Viral vectors having reduced virulence | Chemistry; Metallurgy | 17 | Expired |
| US6750043B2 | Viral vectors having reduced virulence | Chemistry; Metallurgy | 17 | Expired |
| US6846652B2 | Viral vectors having enhanced effectiveness with reduced virulence | Chemistry; Metallurgy | 16 | Expired |
| US7001718B2 | Method of inhibiting pathogenicity of infectious agents | Physics | 15 | Expired |
| US9234197B2 | Genetic element that enhances protein translation | Chemistry; Metallurgy | 15 | Active |
| US10370679B2 | Modified immunization vectors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10842838B2 | Method for the use of botanical extracts in the treatment of viral infections | Human Necessities | 1 | Active |
| US11345928B2 | Modified immunization vectors | Emerging Cross-Sectional Technologies | 1 | Active |
| US10293012B2 | Methods of using extracts of melissa officinalis against filoviruses | Human Necessities | 1 | Active |
| US11458203B2 | Pharmaceutical compositions comprising caffeic acid chelates | Human Necessities | 0 | Active |
| US12364727B2 | Method for treating poxvirus infections | Human Necessities | 0 | Active |
| US11918642B2 | HIV vaccination compositions comprising vaccinia VLPS and plant-produced VLPS presenting HIV antigens | Chemistry; Metallurgy | 0 | Active |
| US12331307B2 | Modified immunization vectors | Emerging Cross-Sectional Technologies | 0 | Active |
| US10842835B2 | Oncolytic vaccinia virus mutants and using same for cancer treatment | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.